Free cash flow rebounded to $331.0M in 2026Q2 (28.1% margin), with cumulative operating cash flow of $2.0B exceeding net income by $0.9B, but aggressive buybacks ($256.9M in 2026Q2) and seasonal working capital swings drive volatility.
Crocs, Inc. (CROX) cash flow statement — 23-year operating, investing & financing cash flows
| Metric | TTM | Dec'25 | Dec'24 | Dec'23 | Dec'22 | Dec'21 | Dec'20 | Dec'19 | Dec'18 | Dec'17 | Dec'16 | Dec'15 | Dec'14 | Dec'13 | Dec'12 | Dec'11 | Dec'10 | Dec'09 | Dec'08 | Dec'07 | Dec'06 | Dec'05 | Dec'04 | Dec'03 |
|---|
| Cash from Operations | 790.42M | 710.43M | 992.49M | 930.44M | 603.14M | 567.16M | 266.9M | 89.96M | 114.16M | 98.26M | 39.75M | 9.7M | -11.65M | 83.46M | 128.13M | 142.38M | 104.27M | 61.11M | 72.86M | 8.94M | 12.34M | 10.5M | 777K | -439K |
| Operating CF Margin % | - | 17.58% | 24.19% | 23.48% | 16.97% | 24.52% | 19.26% | 7.31% | 10.49% | 9.6% | 3.84% | 0.89% | -0.97% | 7% | 11.41% | 14.22% | 13.2% | 9.46% | 10.1% | 1.05% | 3.48% | 9.67% | 5.75% | -37.68% |
| Operating CF Growth % | 3.07% | -28.42% | 6.67% | 54.27% | 6.34% | 112.5% | 196.7% | -21.2% | 16.18% | 147.18% | 309.92% | 183.24% | -113.96% | -34.86% | -10.01% | 36.54% | 70.64% | -16.13% | 715.2% | -27.59% | 17.53% | 1251.61% | 276.99% | - |
| Net Income | 593.42M | 105.17M | 950.07M | 792.57M | 540.16M | 725.69M | 312.86M | 119.5M | 50.44M | 10.24M | -16.49M | -83.2M | -4.93M | 10.42M | 131.34M | 112.79M | 67.73M | -42.08M | -185.08M | 168.23M | 64.42M | 16.97M | -1.49M | -1.2M |
| Depreciation & Amortization | 81.56M | 79.28M | 69.84M | 54.3M | 39.23M | 31.98M | 27.62M | 24.21M | 29.25M | 33.13M | 34.04M | 35.99M | 37.41M | 41.51M | 36.69M | 37.26M | 37.06M | 36.67M | 37.45M | 20.95M | 8.05M | 3.33M | 700K | 75K |
| Stock-Based Compensation | 41.52M | 36.7M | 33.05M | 29.07M | 31.3M | 38.12M | 16.36M | 14.41M | 13.11M | 9.77M | 10.74M | 11.24M | 12.5M | 11.87M | 11.32M | 8.55M | 7.11M | 31.43M | 21.68M | 21.68M | 10.26M | 4.76M | 0 | 0 |
| Deferred Taxes | 33.08M | 47.09M | -254.45M | -410.32M | -4.76M | -241.28M | -325.06M | -16.26M | 959K | -3.09M | -388K | 289K | 829K | 23.54M | -2.98M | -819K | -5M | 5.4M | -5.43M | -14.87M | -2.04M | -3.09M | -191K | 0 |
| Other Non-Cash Items | 121.17M | 589.29M | 125.55M | 98.3M | 88.89M | 57.18M | 102.73M | 59.39M | 8.45M | 3.31M | -2.15M | 47.63M | 24.25M | 11.07M | 19.23M | -9.9M | 5.66M | 24.34M | 148.87M | -51.6M | -10.11M | 1.48M | 1.79M | 356K |
| Working Capital Changes | -80.33M | -147.1M | 68.43M | 366.52M | -91.68M | -44.53M | 132.39M | -111.3M | 11.96M | 44.9M | 14.01M | -2.25M | -81.72M | -14.94M | -67.47M | -5.5M | -8.28M | 5.34M | 55.36M | -135.46M | -58.23M | -12.95M | -30K | 330K |
| Change in Receivables | -13.84M | -6.17M | 42.59M | -13.32M | -56.77M | -35.06M | -47.05M | -15.02M | -24.62M | 620K | 2.41M | -15.6M | -15.29M | -17.17M | -9.47M | -23.28M | -13.16M | -13.25M | -83.95M | -79.28M | -43.98M | -15.2M | 0 | 0 |
| Change in Inventory | 13.15M | -13.84M | 22.05M | 86.35M | -91.61M | -43.06M | -13.46M | -48.16M | -1.99M | 23.32M | 20.37M | -8.59M | -31.25M | -5.27M | -35.49M | -13.33M | -27.91M | 44.83M | 18.24M | -151.59M | -54.96M | -26.04M | -859K | -331K |
| Change in Payables | 93.35M | 709K | 3.95M | 37.2M | 41.7M | 34.87M | 23.23M | 6.03M | 12.95M | -2.71M | -1.35M | 23.26M | -12.11M | -5.74M | 99K | 30.31M | 12.69M | -17.39M | 27.15M | 27.15M | 19.96M | 17.71M | 0 | 0 |
| Cash from Investing | -58.01M | -51.23M | -69.35M | -115.67M | -2.15B | -55.92M | -41.76M | -36.24M | -10.11M | -11.54M | -19.86M | -18.63M | -57.99M | -69.76M | -65.94M | -41.66M | -42.08M | -25.73M | -73.44M | -62.22M | -69.5M | -12.17M | -6.72M | -321K |
| Capital Expenditures | -58.01M | -51.23M | -69.35M | -115.63M | -104.19M | -55.92M | -42.03M | -36.58M | -11.98M | -13.12M | -22.19M | -18.49M | -57.03M | -68.83M | -60.84M | -41.64M | -45.1M | -27.03M | -66.22M | -73.9M | -29.04M | -11.53M | -1.55M | -321K |
| CapEx % of Revenue | 1.43% | 1.27% | 1.69% | 2.92% | 2.93% | 2.42% | 3.03% | 2.97% | 1.1% | 1.28% | 2.14% | 1.7% | 4.76% | 5.77% | 5.42% | 4.16% | 5.71% | 4.19% | 9.18% | 8.72% | 8.19% | 10.62% | 11.47% | 27.55% |
| Acquisitions | 0 | 0 | 0 | 0 | -2.05B | 6K | 463K | 0 | 0 | 0 | 0 | -2K | 0 | 0 | -5.17M | -15.32M | -12.57M | 0 | -7.98M | -12.39M | -15.4M | 0 | -5.17M | 0 |
| Investments | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Investing | 0 | 0 | 0 | -46K | -20K | -15K | -192K | 340K | 1.87M | 1.58M | 2.34M | -139K | -966K | -930K | 62K | 13.58M | 13.89M | 2.8M | -21.57M | 1.75M | -2.73M | 0 | 0 | 0 |
| Cash from Financing | -756.5M | -714.57M | -886.05M | -859.64M | 1.53B | -429.64M | -198.04M | -68.64M | -148.8M | -65.37M | -16.44M | -101.26M | 23.43M | -1.16M | -16.4M | 8.92M | 5.25M | -22.19M | 18.6M | 43.2M | 94.55M | 5.53M | 6.64M | 1.01M |
| Debt Issued (Net) | -108.79M | -128M | -323.25M | -665.8M | 1.59B | 605M | -25M | 85M | 119.34M | -3.11M | -4.04M | -5.29M | -5.18M | 10.21M | 5.46M | -1.11M | -1.52M | -22.79M | 15.32M | 6.46M | -12.26M | 8.8M | 767K | 400K |
| Equity Issued (Net) | -647.58M | -582.32M | -560.69M | -192.1M | -11.48M | -1.02B | -173.89M | -148.72M | -246.85M | -50M | 420K | -85.93M | 36.92M | -11.28M | -21.86M | 10.42M | 6.77M | -238K | 3.28M | -6.47M | 96.74M | -275K | 5.88M | 613K |
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -2.98M | -21.02M | -12M | -12M | -11.9M | -8.23M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -171K | -275K | 0 | 0 |
| Share Repurchases | -647.58M | -582.32M | -560.69M | -192.1M | -11.48M | -1.02B | -173.89M | -148.72M | -246.85M | -50M | -324K | -85.93M | -146.65M | -12.79M | -25.57M | -490K | -421K | -238K | 0 | -25.02M | 0 | -275K | -150K | -12K |
| Other Financing | -141K | -4.25M | -2.11M | -1.74M | -53.48M | -14.52M | 854K | -1.94M | -270K | -259K | -818K | 1.86M | -75K | -100K | -225K | -398K | 0 | 832K | 0 | 43.22M | 10.25M | 275K | 0 | 0 |
| Net Change in Cash | -30.24M | -49.77M | 30.58M | -41.79M | -22.04M | 77.65M | 27.23M | -15.48M | -49.52M | 24.56M | 4.22M | -124.17M | -49.63M | 22.8M | 36.76M | 112M | 68.24M | 25.68M | 15.33M | -6.32M | 37.87M | 3.73M | 728K | 253K |
| Free Cash Flow | 732.41M | 659.2M | 923.14M | 814.82M | 498.95M | 511.25M | 224.87M | 53.38M | 102.18M | 85.15M | 17.56M | -8.79M | -68.68M | 14.64M | 67.3M | 100.74M | 59.17M | 34.08M | 6.64M | -64.97M | -16.7M | -1.03M | -774K | -760K |
| FCF Margin % | 18.06% | 16.31% | 22.5% | 20.56% | 14.04% | 22.1% | 16.22% | 4.34% | 9.39% | 8.32% | 1.69% | -0.81% | -5.73% | 1.23% | 5.99% | 10.06% | 7.49% | 5.28% | 0.92% | -7.67% | -4.71% | -0.95% | -5.72% | -65.24% |
| FCF Growth % | -4.75% | -28.59% | 13.29% | 63.31% | -2.41% | 127.35% | 321.25% | -47.76% | 20.01% | 384.89% | 299.77% | 87.2% | -569.23% | -78.25% | -33.2% | 70.25% | 73.61% | 412.9% | 110.23% | -288.99% | -1523.03% | -32.95% | -1.84% | - |
| FCF per Share | 14.60 | 12.16 | 15.43 | 13.15 | 8.05 | 8.02 | 3.28 | 0.74 | 1.49 | 1.18 | 0.24 | -0.12 | -0.81 | 0.17 | 0.74 | 1.11 | 0.68 | 0.40 | 0.08 | -0.77 | -0.10 | -0.02 | -0.02 | -0.01 |
| FCF Conversion (FCF/Net Income) | 1.23x | -8.75x | 1.04x | 1.17x | 1.12x | 0.78x | 0.85x | 0.75x | 2.26x | 9.60x | -2.41x | -0.12x | 2.37x | 8.01x | 0.98x | 1.26x | 1.54x | -1.45x | -0.39x | 0.05x | 0.19x | 0.62x | -0.52x | 0.37x |
| Interest Paid | 26.48M | 0 | 99.46M | 151.62M | 127.81M | 10.21M | 6.66M | 7.52M | 462K | 434K | 653K | 917K | 616K | 693K | 619K | 843K | 639K | 1.49M | 0 | 0 | 0 | 0 | 0 | 0 |
| Taxes Paid | 19.61M | 0 | 124.96M | 179.72M | 130.08M | 159.68M | 20.82M | 16.05M | 18.63M | 13.21M | 12.34M | 19.92M | 33.66M | 20.27M | 29.39M | 26.63M | 11.05M | 12.39M | 0 | 0 | 0 | 0 | 0 | 0 |
Quick answers to the most common questions about buying CROX stock.
Crocs, Inc. (CROX) generated $710.4M in net cash from operating activities in 2025. This reflects the cash generated directly from core business operations.
Crocs, Inc. (CROX) generated $659.2M in free cash flow in 2025. Free cash flow is the cash left over after capital expenditures, which can be used to pay dividends, repurchase shares, or pay down debt.
Crocs, Inc. (CROX) spent $51.2M on capital expenditures in 2025. CapEx represents the cash invested in physical assets like property, plant, and equipment to maintain or grow the business.
In 2025, Crocs, Inc. (CROX) spent $582.3M on share repurchases. This shows the company's commitment to returning capital to its equity investors.
Key Metrics
Top Statement Risk
Unresolved net margin divergence
Metrics are mathematically derived from official filings.
Cash Conversion Volatility Masks Operating Strength
CROX's operating cash flow to net income ratio swung from -0.58 in 2025Q2 to 1.72 in 2026Q2, reflecting non-cash charges and working capital swings. According to the latest quarterly data, the 2025Q2 net loss of $492.3M contrasts with $285.8M operating cash flow.
The negative OCF/NI ratios in 2025Q1 and 2025Q2 are driven by large working capital outflows, not operational deterioration, as operating cash flow remained positive in 2025Q2. The 2026Q2 ratio of 1.72 indicates high earnings quality, with cash conversion exceeding net income due to non-cash add-backs and favorable working capital. Investors should monitor the recurring working capital swings, which appear seasonal and may distort quarterly comparisons.
Free Cash Flow Rebounding After Seasonal Dip
FCF margin recovered to 28.1% in 2026Q2 from -7.7% in 2026Q1, with FCF of $331.0M versus $204.9M net income. As reported in the cash flow statement, the trailing twelve-month FCF margin stands at approximately 18%, supported by strong operating cash generation.
The first-quarter negative FCF is a recurring seasonal pattern, as working capital builds ahead of spring/summer demand. The 2026Q2 FCF of $331.0M is the highest in the ten-quarter period, suggesting improving operational efficiency and brand momentum. However, the 2025Q2 net loss of $492.3M did not impact cash flow, indicating the loss was non-cash, which supports the quality of the underlying cash generation.
Low Capital Intensity Preserves Cash Flow
CapEx averaged just 1.5% of revenue over the past ten quarters, with 2026Q2 at 1.8%, reflecting the asset-light injection-molding model. Based on the cash flow data, CapEx of $20.7M in 2026Q2 is minimal relative to $1.18B revenue, enabling high FCF conversion.
The low capital intensity is a structural advantage, as the single-mold production process requires limited ongoing investment. Maintenance capex appears sufficient to sustain operations, with D&A of $20.0M roughly matching CapEx, suggesting no significant underinvestment. This allows CROX to allocate substantial cash to buybacks and debt reduction, as evidenced by $256.9M in buybacks in 2026Q2.
Seasonal Working Capital Swings Drive Cash Flow Volatility
Working capital changes swung from -$292.1M in 2025Q1 to +$167.7M in 2024Q4, with 2026Q2 showing a $81.0M positive contribution. According to the cash flow statement, these swings are the primary driver of quarterly OCF volatility, not operational deterioration.
The negative working capital changes in Q1 quarters reflect inventory builds ahead of peak selling season, while Q4 and Q2 show positive contributions from collections and payables management. The 2026Q2 positive $81.0M suggests efficient inventory and receivables management, supporting the strong cash conversion. Investors should expect continued seasonal volatility, but the underlying trend appears stable with no evidence of structural working capital deterioration.
Aggressive Buybacks Despite Net Loss Quarter
CROX repurchased $256.9M in 2026Q2, the highest in the period, even as net income was $204.9M. As reported in the cash flow statement, buybacks totaled over $1.4B in the last ten quarters, funded by robust operating cash flow, with no dividends paid.
The capital deployment strategy prioritizes share repurchases, which appear accretive given the low valuation relative to peers. The 2025Q2 buyback of $133.3M despite a net loss indicates management's confidence in cash generation and long-term value. However, the lack of dividends and heavy buyback reliance may signal limited alternative investment opportunities, and the elevated leverage (D/E of 1.25) warrants monitoring.
Cumulative Cash Generation Exceeds Net Income
Over the ten quarters, cumulative operating cash flow of $2.0B exceeds cumulative net income of $1.1B, a gap of $0.9B. Based on the cash flow data, this divergence highlights the impact of non-cash charges, particularly the 2025Q2 impairment, and suggests robust cash earnings power.
The cumulative OCF/NI ratio of approximately 1.8 indicates that reported net income understates cash generation, largely due to non-cash charges like impairments and D&A. This supports the view that the negative net margin in 2025Q2 was a one-time event, not a recurring operational issue. However, the persistent gap between operating margin and net margin in the TTM period suggests ongoing non-operating costs that investors should continue to scrutinize.
What the Cash Flow Statement Obscures
Despite strong operating cash flow, the persistent gap between operating margin (22.0%) and net margin (-2.0%) suggests non-cash charges or interest that may not be fully captured in cash flow. As reported in the cash flow data, SBC of $14.2M in 2026Q2 is modest, but the unresolved net margin divergence warrants forensic review.
The cash flow statement shows robust OCF, but the TTM net margin of -2.0% versus operating margin of 22.0% implies significant non-operating drags, likely interest or impairments, that are not visible in operating cash flow. The elevated Debt/Equity of 1.25, if accurate, suggests leverage that could amplify downside risk, though the cash flow data does not directly reveal the nature of these costs. Investors should monitor whether these non-operating items are recurring, as they could erode the apparent cash generation strength.